A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Ohio joins Midwest XOR’s roster
Ohio University has signed up to a Kentucky-led online portal aimed at sourcing C-level executives for university-linked businesses.
VTT winds down Spinnova stake
VTT Ventures has exited textile fibre developer Spinnova, spun out from the research centre in 2014.
Serum braces for Vakzine acquisition
The vaccine developer had been backed by Helmholtz’s tech transfer partner Ascenion, its sponsor association Friends of the HZI and pharmaceutical consultancy Corvay.
Principia Biopharma primes $86m IPO
Principia Biopharma, whose drug discovery platform is based on research at UCSF, has filed for an $86.3m initial public offering having raised $50m earlier this month.
Nexgen reaps $2.2m
Queensland crop breeding spinout Nexgen Plants has been backed by multi-university venture fund Uniseed, Business Development Fund and Yuuwa Capital.
IP Group fills in Crossword on partnership
IP Group has joined forces with tech transfer company Crossword Cybersecurity to target the launch of more cybersecurity spinouts.
Prapela grows out of Harvard research
Prapela will commercialise medical devices for infants administering to fight drug withdrawal and cardiorespiratory problems.
Dexcom collects TypeZero
Diabetes management device manufacturer TypeZero has become University of Virginia Licensing and Ventures Group Seed Fund’s first exit.
RXQ compounds $3.6m in funding
RXQ Compounding, backed by Ohio Innovation Fund, has added $3.6m in series A funding from Advantage Capital to its coffers.
Apogen regenerates series A
Merck Group has joined existing investors to provide a $4m extension that brought the total for Minnesota spinout Apogen’s series A round to $11m.


